Literature DB >> 28111121

Risk factors for the onset and progression of Huntington disease.

Ting-Kuang Chao1, Jing Hu2, Tamara Pringsheim3.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by chorea, behavioural and psychiatric manifestations, and dementia, caused by a CAG triplet repeat expansion in the huntingtin gene. Systematic review of the literature was conducted to determine the risk factors for the onset and progression of HD. Multiple databases were searched, using terms specific to Huntington disease and to studies of aetiology, risk, prevention and genetics, limited to studies on human subjects published in English or French between 1950 and 2010. Two reviewers independently screened the abstracts and identified potentially relevant articles for full-text review using predetermined inclusion criteria. Three major categories of risk factors for onset of HD were identified: CAG repeat length in the huntingtin gene, CAG instability, and genetic modifiers. Of these, CAG repeat length in the huntingtin gene is the most important risk factor. For the progression of HD: genetic, demographic, past medical/clinical and environmental risk factors have been studied. Of these factors, genetic factors appear to play the most important role in the progression of HD. Among the potential risk factors, CAG repeat length in the mutant allele was found to be a relatively consistent and significant risk factor for the progression of HD, especially in motor, cognitive, and other neurological symptom deterioration. In addition, there were many consistent results in the literature indicating that a higher number of CAG repeats was associated with shorter survival, faster institutionalization, and earlier percutaneous endoscopic gastrostomy.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CAG; Huntingtin gene; Onset; Prevalence; Progression; Systematic review

Mesh:

Substances:

Year:  2017        PMID: 28111121     DOI: 10.1016/j.neuro.2017.01.005

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  8 in total

Review 1.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

Review 2.  The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta-Analysis.

Authors:  Moamen Mostafa Asla; Asmaa Ahmed Nawar; Alaa Abdelsalam; Esraa Elsayed; Marwa Abdelazim Rizk; Mohamed Alaa Hussein; Walaa A Kamel
Journal:  Mov Disord Clin Pract       Date:  2021-10-29

Review 3.  Huntington's Chorea-a Rare Neurodegenerative Autosomal Dominant Disease: Insight into Molecular Genetics, Prognosis and Diagnosis.

Authors:  Pratik Talukder; Annapurna Jana; Shrirupa Dhar; Saikat Ghosh
Journal:  Appl Biochem Biotechnol       Date:  2021-07-07       Impact factor: 2.926

Review 4.  Therapeutic implication of autophagy in neurodegenerative diseases.

Authors:  Md Ataur Rahman; Hyewhon Rhim
Journal:  BMB Rep       Date:  2017-07       Impact factor: 4.778

5.  The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's Disease.

Authors:  Jordan L Schultz; Amelia D Moser; Peg C Nopoulos
Journal:  Brain Sci       Date:  2020-08-20

Review 6.  Repetitive Elements in Humans.

Authors:  Thomas Liehr
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

7.  Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis.

Authors:  Matteo Riccò; Luigi Vezzosi; Federica Balzarini; Giovanni Gualerzi; Silvia Ranzieri
Journal:  Acta Biomed       Date:  2020-04-10

8.  Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents.

Authors:  Muhammad Afzal; Nadeem Sayyed; Khalid Saad Alharbi; Sami I Alzarea; Mohammed Salem Alshammari; Fadhel A Alomar; Sattam Khulaif Alenezi; Anwarulabedin Mohsin Quazi; Abdulaziz I Alzarea; Imran Kazmi
Journal:  Biomolecules       Date:  2022-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.